UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049149
Receipt number R000055987
Scientific Title Survey of anti-CGRP monoclonal antibodies in Japan
Date of disclosure of the study information 2022/10/07
Last modified on 2023/01/23 07:08:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey of anti-CGRP monoclonal antibodies in Japan

Acronym

Survey of anti-CGRP monoclonal antibodies in Japan

Scientific Title

Survey of anti-CGRP monoclonal antibodies in Japan

Scientific Title:Acronym

Survey of anti-CGRP monoclonal antibodies in Japan

Region

Japan


Condition

Condition

Migraine

Classification by specialty

Medicine in general Neurology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify how Japanese doctors decide to prescribe CGRPmAbs etc.

Basic objectives2

Others

Basic objectives -Others

To clarify number of migraineurs doctors are seeing, and their time with each patient etc.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Criteria for prescribing CGRPmAbs

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Members of The Japanese Headache Society (Medical Doctors)

Key exclusion criteria

Non-medical doctors

Target sample size



Research contact person

Name of lead principal investigator

1st name Tsubasa
Middle name
Last name Takizawa

Organization

Keio University School of Medicine

Division name

Department of Neurology

Zip code

160-8582

Address

35 Shinanomachi, Shijuku-ku, Tokyo

TEL

0353633788

Email

tsubasa.takizawa@z5.keio.jp


Public contact

Name of contact person

1st name Tsubasa
Middle name
Last name Takizawa

Organization

Keio University School of Medicine

Division name

Department of Neurology

Zip code

160-8582

Address

35 Shinanomachi, Shijuku-ku, Tokyo

TEL

0353633788

Homepage URL


Email

tsubasa.takizawa@z5.keio.jp


Sponsor or person

Institute

Department of Neurology, Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Task force for the use of anti-CGRP monoclonal antibodies, The Japanese Headache Society

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine

Address

35 Shinanomachi, Shijuku-ku, Tokyo

Tel

0353633788

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 09 Month 27 Day

Date of IRB

2022 Year 09 Month 27 Day

Anticipated trial start date

2022 Year 12 Month 22 Day

Last follow-up date

2033 Year 01 Month 22 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

n/a


Management information

Registered date

2022 Year 10 Month 07 Day

Last modified on

2023 Year 01 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055987


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name